Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anhedonia as a Key Clinical Feature in the Maintenance and Treatment of Opioid Use Disorder
Brian D. Kiluk, Sarah W. Yip, Elise E. DeVito, et al.
Clinical Psychological Science (2019) Vol. 7, Iss. 6, pp. 1190-1206
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Opioid-driven disruption of the septal complex reveals a role for neurotensin-expressing neurons in withdrawal
Rhiana C. Simon, Weston Fleming, P. Senthilkumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
Mindful positive emotion regulation as a treatment for addiction: from hedonic pleasure to self-transcendent meaning
Eric L. Garland
Current Opinion in Behavioral Sciences (2021) Vol. 39, pp. 168-177
Open Access | Times Cited: 54
Opioid-induced microglia reactivity modulates opioid reward, analgesia, and behavior
Jacob M. Green, Mark Sundman, Ying‐hui Chou
Neuroscience & Biobehavioral Reviews (2022) Vol. 135, pp. 104544-104544
Open Access | Times Cited: 32
Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use.
Rachel V. Aaron, Patrick H Finan, Stephen T. Wegener, et al.
American Psychologist (2020) Vol. 75, Iss. 6, pp. 796-810
Open Access | Times Cited: 42
Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards
Eric L. Garland, Spencer T. Fix, Justin Hudak, et al.
Psychological Medicine (2021) Vol. 53, Iss. 5, pp. 2085-2094
Open Access | Times Cited: 36
Daily profiles of nondrug reward and their association with daily outcomes for people in recovery from opioid use disorder: An application of latent profile analysis applied to intensive longitudinal data
Samuel W. Stull, Lisa A. Marsch, Stephanie T. Lanza
Drug and Alcohol Dependence (2025) Vol. 271, pp. 112646-112646
Closed Access
The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies
Isabell M. Meier, Marie Eikemo, Siri Leknes
Current Addiction Reports (2021) Vol. 8, Iss. 2, pp. 306-318
Open Access | Times Cited: 30
Mindfulness‐Oriented Recovery Enhancement: Implementing an evidence‐based intervention for chronic pain, opioid use, and opioid addiction in clinical settings
Eric L. Garland
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 12, pp. 3028-3035
Open Access | Times Cited: 4
The Neural Substrates of Individual Differences in Reward Sensitivity in Mental Health
David H. Zald, Nicholas J. Dennis
(2025), pp. 113-155
Closed Access
Psychosocial intervention and the reward system in pain and opioid misuse: new opportunities and directions
Eric L. Garland
Pain (2020) Vol. 161, Iss. 12, pp. 2659-2666
Open Access | Times Cited: 29
The Developmental Origins of Opioid Use Disorder and Its Comorbidities
S Levis, Stephen V. Mahler, Tallie Z. Baram
Frontiers in Human Neuroscience (2021) Vol. 15
Open Access | Times Cited: 24
Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail
Hanis Mohammad Hazani, Isa Naina Mohamed, Muzaimi Mustapha, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
From Computation to Clinic
Sarah W. Yip, Deanna M. Barch, Henry W. Chase, et al.
Biological Psychiatry Global Open Science (2022) Vol. 3, Iss. 3, pp. 319-328
Open Access | Times Cited: 16
Using the Beck Depression Inventory to Assess Anhedonia: A Scale Validation Study
Ashby Cogan, Jacqueline B. Persons, Ann M. Kring
Assessment (2023) Vol. 31, Iss. 2, pp. 431-443
Open Access | Times Cited: 10
From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder
Jeremy Weleff, Julio C. Nunes, Gabriel P. A. Costa, et al.
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 3
The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder
Zhenhao Shi, Kanchana Jagannathan, James H. Padley, et al.
Addiction Biology (2020) Vol. 26, Iss. 4
Closed Access | Times Cited: 21
Differential effects of acute and prolonged morphine withdrawal on motivational and goal‐directed control over reward‐seeking behaviour
Briac Halbout, Collin Hutson, Stuti Agrawal, et al.
Addiction Biology (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 2
Higher anhedonia during withdrawal from initial opioid exposure is protective against subsequent opioid self-administration in rats
Yayi Swain, Peter Muelken, Annika Skansberg, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2279-2291
Open Access | Times Cited: 19
Sleep Deficiency and Opioid Use Disorder
Jennifer Langstengel, H. Klar Yaggi
Clinics in Chest Medicine (2022) Vol. 43, Iss. 2, pp. e1-e14
Open Access | Times Cited: 12
Endogenous opiates and behavior: 2019
Richard J. Bodnar
Peptides (2021) Vol. 141, pp. 170547-170547
Closed Access | Times Cited: 15
The association of prefrontal cortex response during a natural reward cue-reactivity paradigm, anhedonia, and demoralization in persons maintained on methadone
Andrew S. Huhn, Robert K. Brooner, Mary M. Sweeney, et al.
Addictive Behaviors (2020) Vol. 113, pp. 106673-106673
Open Access | Times Cited: 15
Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder
Jennifer D. Ellis, Chung Jung Mun, David H. Epstein, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 10, pp. 1836-1843
Open Access | Times Cited: 9
Depressive-like Behavior Is Accompanied by Prefrontal Cortical Innate Immune Fatigue and Dendritic Spine Losses after HIV-1 Tat and Morphine Exposure
Sara R. Nass, Yun K. Hahn, Michael Ohene‐Nyako, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 590-590
Open Access | Times Cited: 5
I feel good? Anhedonia might not mean “without pleasure” for people treated for opioid use disorder.
Samuel W. Stull, Jeremiah W. Bertz, Leigh V. Panlilio, et al.
Journal of Abnormal Psychology (2021) Vol. 130, Iss. 5, pp. 537-549
Open Access | Times Cited: 11
Food selection in a buffet scenario by persons in recovery from substance use disorder: Testing a parallel mediation model including impulsivity, food craving, and breadth of drug use
Laurence J. Nolan
Physiology & Behavior (2024) Vol. 275, pp. 114458-114458
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top